Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AVE8062 plus cisplatin vs placebo plus cisplatin in advanced soft tissue sarcoma after anthracycline and ifosfamide failure
2007-003592-39Phase 3Completed
- Sponsor
- Sanofi
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in soft tissue sarcoma (STS) comparing AVE8062 plus cisplatin with Placebo plus cisplatin (2 arms). Primary endpoint: Progression-free survival. Started Feb 2008; status: completed.
02
Drugs
Ombrabulin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2007-003592-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003592-39.